| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $537.8M | +0.5% |
| Cost of Revenue | $114.9M | -0.0% |
| Gross Profit | $423.0M | +0.7% |
| R&D Expense | $206.1M | +2.4% |
| SG&A Expense | $132.8M | +5.3% |
| Operating Income | -$89.5M | -101.9% |
| Interest Expense | $8.1M | -8.2% |
| Pre-tax Income | -$81.8M | -57.2% |
| Income Tax | $10.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $115.3M | -44.8% |
| Accounts Receivable | $86.3M | -7.8% |
| Inventory | $29.4M | +20.3% |
| Current Assets | $1.11B | +3.5% |
| Total Assets | $1.19B | +4.6% |
| Current Liabilities | $158.8M | +11.3% |
| Long-term Debt | $565.5M | +0.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $30.8M | -62.8% |
| Capital Expenditures | $21.4M | -11.6% |
| Investing Cash Flow | -$140.0M | +3.4% |
| Financing Cash Flow | $15.5M | -39.7% |
| Free Cash Flow | $9.4M | -83.9% |
| +70.3% |
| Net Income | -$92.5M | -58.6% |
| EPS (Basic) | -$0.88 | -57.1% |
| EPS (Diluted) | -$0.88 | -57.1% |
| Total Liabilities |
| $750.5M |
| +2.9% |
| Stockholders' Equity | $441.2M | +7.5% |